Varex Imaging (NASDAQ:VREX) Releases Earnings Results

Varex Imaging (NASDAQ:VREX) posted its earnings results on Thursday. The company reported $0.16 EPS for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.07), Briefing.com reports. The business had revenue of $206.20 million during the quarter, compared to the consensus estimate of $205.15 million. Varex Imaging had a return on equity of 9.21% and a net margin of 5.08%. The firm’s revenue for the quarter was down 9.6% on a year-over-year basis. During the same period in the previous year, the business posted $0.26 EPS. Varex Imaging updated its Q3 guidance to $0.05 to $0.25 EPS.

Varex Imaging Stock Performance

Shares of VREX stock traded down $0.84 on Friday, reaching $15.59. The stock had a trading volume of 1,030,491 shares, compared to its average volume of 327,836. The stock has a market cap of $632.95 million, a P/E ratio of 16.24, a price-to-earnings-growth ratio of 2.39 and a beta of 0.72. Varex Imaging has a 1 year low of $14.56 and a 1 year high of $23.90. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.37 and a current ratio of 4.30. The company has a 50 day simple moving average of $17.32 and a 200 day simple moving average of $18.49.

Wall Street Analyst Weigh In

Separately, TheStreet lowered Varex Imaging from a “b-” rating to a “c” rating in a report on Tuesday, February 6th.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.